Announcement

Collapse
No announcement yet.

Infect Dis Ther . Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
    No photos found.
Working...
X